Armistice Capital »

Nextcure shares owned by Armistice Capital

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $57k 36k 1.59

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Nextcure

Sofinnova Ventures
Logos Global Management
Affinity Asset Advisors
OrbiMed Advisors
Vanguard Group
BlackRock
BlackRock
Tang Capital Management
Cable Car Capital
Long Focus Capital Management
Acadian Asset Management
Renaissance Technologies
Acuitas Investments
Federated Investors
BML Capital Management

View all funds holding Nextcure